Skip to main content

Fentanyl News (Page 4)

FDA Medwatch Alert: Opioid Pain Medicines: Drug Safety Communication - New Safety Warnings Added to Prescription Opioid Medications

ISSUE: FDA is warning about several safety issues with the entire class of opioid pain medicines. See the FDA Drug Safety Communication for a complete listing. These safety risks are potentially h...

FDA Medwatch Alert: Compounded Drugs Stored in Becton-Dickinson (BD) 3 ml and 5 ml Syringes: FDA Warning - Do Not Use

ISSUE: FDA is alerting health care professionals not to administer to patients compounded or repackaged drugs that have been stored in 3 milliliter (ml) and 5ml syringes manufactured by...

Insys Therapeutics Announces FDA Approval of Subsys Fentanyl Sublingual Spray

PHOENIX, Jan 5, 2012 - INSYS Therapeutics announces the US Food and Drug Administration approval of its branded breakthrough cancer pain medication, Subsys fentanyl sublingual spray. SUBSYS is a...

FDA Approves Lazanda - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients

READING, England and BEDMINSTER, N.J., June 30, 2011 /PRNewswire/ – Archimedes Pharma Ltd., and its subsidiary, Archimedes Pharma U.S. Inc., today announced that the U.S. Food and Drug...

FDA Approval for Abstral (Fentanyl) Sublingual Tablets

Uppsala, January 10, 2011 - Orexo AB announces today that its partner ProStrakan Group plc has received approval from the US Food and Drug Administration (FDA) for Abstral. Abstral is licensed for...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Anesthesia, Breakthrough Pain, Chronic Pain, Pain, Sedation

Fentanyl patient information at Drugs.com